SWLVX
Price
$16.12
Change
-$0.20 (-1.23%)
Updated
Nov 13 closing price
Net Assets
926.11M
VIVAX
Price
$73.17
Change
-$0.74 (-1.00%)
Updated
Nov 13 closing price
Net Assets
207.95B
Interact to see
Advertisement

SWLVX vs VIVAX

Header iconSWLVX vs VIVAX Comparison
Open Charts SWLVX vs VIVAXBanner chart's image
Schwab ® US Large-Cap Value Index
Price$16.12
Change-$0.20 (-1.23%)
VolumeN/A
Net Assets926.11M
Vanguard Value Index I
Price$73.17
Change-$0.74 (-1.00%)
VolumeN/A
Net Assets207.95B
SWLVX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
SWLVX vs. VIVAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SWLVX is a Hold and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. SWLVX (926M). VIVAX pays higher dividends than SWLVX: VIVAX (1.98) vs SWLVX (1.82). SWLVX was incepted earlier than VIVAX: SWLVX (8 years) vs VIVAX (33 years). VIVAX (0.17) is less costly to investors than SWLVX (0.04). SWLVX is a more actively managed with annual turnover of: 30.97 vs. VIVAX (9.00). SWLVX has a lower initial minimum investment than VIVAX: SWLVX (0) vs VIVAX (3000). SWLVX annual gain was more profitable for investors over the last year : 513.44 vs. VIVAX (5.48). SWLVX return over 5 years is better than : 1948.84 vs. VIVAX (64.67).
SWLVXVIVAXSWLVX / VIVAX
Total Expense Ratio0.040.1721%
Annual Report Gross Expense Ratio0.040.1721%
Fund Existence8 years33 years-
Gain YTD356.02510.8443,283%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets926M208B0%
Annual Yield % from dividends1.821.9892%
Returns for 1 year513.445.489,377%
Returns for 3 years1143.5232.943,472%
Returns for 5 years1948.8464.673,014%
Returns for 10 yearsN/A129.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LUCD1.110.07
+6.73%
Lucid Diagnostics
FUTU186.19-0.37
-0.20%
Futu Holdings Limited
VYNE0.35-0.01
-1.65%
VYNE Therapeutics
BFS29.62-0.59
-1.95%
Saul Centers
HNGE42.33-1.98
-4.47%
Hinge Health Inc.